trial

Establishing a Clinical Database and Biobank for Schizophrenia：A Cohort Study

NCTId NCT06123897
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Recruiting
Enrollment 2,000 (estimated)
Sponsored by Central South University
Primary completion 2028-07-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
2,000 (estimated)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2024-01-01
Primary completion
2028-07-01
Eligibility
ALL

Interventions & indications

Drugs
Regular follow-up assessments without intervention.Cross-sectional assessment

Sponsors

Central South UniversityLead Sponsor
The First Affiliated Hospital of Zhengzhou UniversityCollaborator
The Affiliated Brain Hospital of Nanjing Medical UniversityCollaborator
Anhui Mental Health CenterCollaborator

Investigators

1
Renrong Wu, M.D., Ph.D.Study Chair

Sites

4 total
Hefei, ChinaZhengzhou, ChinaChangsha, ChinaNanjing, China

Facts & assertions

4 sourced
Enrollment
2,000
Phase
NA
Primary Completion Date
2028-07-01
Status
RECRUITING
relationships
The graph out of here
drug
Regular follow-up assessments without intervention.
drug
Cross-sectional assessment
drug
lead_sponsor
Central South University
company
collaborator
The First Affiliated Hospital of Zhengzhou University
company
The Affiliated Brain Hospital of Nanjing Medical University
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Renrong Wu, M.D., Ph.D.
person